This post was originally published on this site
Irvine-based enVVeno Medical Corp. (Nasdaq: NVNO) has appointed Jennifer Bright as chief financial officer.
Bright replaces previous CFO Craig Glynn.
“In addition to overseeing our financial strategy and operations, Jennifer will play a critical role in strengthening our financial infrastructure, supporting our commercialization efforts for VenoValve, and expanding our relationships with institutional investors and analysts,” Chief Executive Robert Berman said in a statement.
Bright, counting over 25 years of financial and strategic leadership experience, has worked at several medical device and pharmaceutical companies such as Biolase, Apria Healthcare and Smile Brands. She also holds technical accounting and auditing experience from PricewaterhouseCoopers LLP.
Shares of the medical device maker, focused on the treatment of deep venous disease, were up 1.7% to $3.68 apiece with a market cap of $65 million during midday trading.